TY - JOUR AU - Pasin, E. AU - Josephson, D. Y. AU - Mitra, A. P. AU - Cote, R. J. AU - Stein, J. P. PY - 2008 DA - 2008// TI - Superficial bladder cancer: an update on etiology, molecular development, classification, and natural history JO - Rev Urol VL - 10 ID - Pasin2008 ER - TY - STD TI - Muscle-invasive and metastatic bladder cancer - EAU guidelines 2015 [Internet]. http://uroweb.org/wp-content/uploads/07-Muscle-Invasive-BC_LR.pdf. Accessed 11 July 2016. UR - http://uroweb.org/wp-content/uploads/07-Muscle-Invasive-BC_LR.pdf ID - ref2 ER - TY - STD TI - Globocan. Table by populations (Incidence/Mortality) [Internet]. 2012. http://globocan.iarc.fr/Pages/summary_table_site_sel.aspx. Accessed 11 July 2016. UR - http://globocan.iarc.fr/Pages/summary_table_site_sel.aspx ID - ref3 ER - TY - JOUR AU - Rosenberg, J. E. AU - Carroll, P. R. AU - Small, E. J. PY - 2005 DA - 2005// TI - Update on chemotherapy for advanced bladder cancer JO - J Urol VL - 174 UR - https://doi.org/10.1097/01.ju.0000162039.38023.5f DO - 10.1097/01.ju.0000162039.38023.5f ID - Rosenberg2005 ER - TY - JOUR AU - Sternberg, C. N. AU - Vogelzang, N. J. PY - 2003 DA - 2003// TI - Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers JO - Crit Rev Oncol Hematol VL - 46 Suppl UR - https://doi.org/10.1016/S1040-8428(03)00068-4 DO - 10.1016/S1040-8428(03)00068-4 ID - Sternberg2003 ER - TY - JOUR AU - Maase, H. AU - Sengelov, L. AU - Roberts, J. T. AU - Ricci, S. AU - Dogliotti, L. AU - Oliver, T. PY - 2005 DA - 2005// TI - Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.07.757 DO - 10.1200/JCO.2005.07.757 ID - Maase2005 ER - TY - JOUR AU - Bellmunt, J. AU - Petrylak, D. P. PY - 2012 DA - 2012// TI - New therapeutic challenges in advanced bladder cancer JO - Semin Oncol VL - 39 UR - https://doi.org/10.1053/j.seminoncol.2012.08.007 DO - 10.1053/j.seminoncol.2012.08.007 ID - Bellmunt2012 ER - TY - JOUR AU - Bellmunt, J. AU - Orsola, A. AU - Leow, J. J. AU - Wiegel, T. AU - Santis, M. AU - Horwich, A. PY - 2014 DA - 2014// TI - Bladder cancer: ESMO Practice Guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 25 UR - https://doi.org/10.1093/annonc/mdu223 DO - 10.1093/annonc/mdu223 ID - Bellmunt2014 ER - TY - JOUR AU - Dash, A. AU - Galsky, M. D. AU - Vickers, A. J. AU - Serio, A. M. AU - Koppie, T. M. AU - Dalbagni, G. PY - 2006 DA - 2006// TI - Impact of renal impairment on eligibility for adjuvant cisplatin-based chemotherapy in patients with urothelial carcinoma of the bladder JO - Cancer VL - 107 UR - https://doi.org/10.1002/cncr.22031 DO - 10.1002/cncr.22031 ID - Dash2006 ER - TY - JOUR AU - Milowsky, M. I. AU - Rumble, R. B. AU - Booth, C. M. AU - Gilligan, T. AU - Eapen, L. J. AU - Hauke, R. J. PY - 2016 DA - 2016// TI - Guideline on Muscle-Invasive and Metastatic Bladder Cancer (European Association of Urology Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.65.9797 DO - 10.1200/JCO.2015.65.9797 ID - Milowsky2016 ER - TY - JOUR AU - Leow, J. J. AU - Martin-Doyle, W. AU - Rajagopal, P. S. AU - Patel, C. G. AU - Anderson, E. M. AU - Rothman, A. T. PY - 2014 DA - 2014// TI - Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials JO - Eur Urol VL - 66 UR - https://doi.org/10.1016/j.eururo.2013.08.033 DO - 10.1016/j.eururo.2013.08.033 ID - Leow2014 ER - TY - JOUR AU - Galsky, M. D. AU - Stensland, K. D. AU - Moshier, E. AU - Sfakianos, J. P. AU - McBride, R. B. AU - Tsao, C. -. K. PY - 2016 DA - 2016// TI - Effectiveness of Adjuvant Chemotherapy for Locally Advanced Bladder Cancer JO - J Clin Oncol VL - 34 UR - https://doi.org/10.1200/JCO.2015.64.1076 DO - 10.1200/JCO.2015.64.1076 ID - Galsky2016 ER - TY - JOUR AU - Bellmunt, J. AU - Choueiri, T. K. AU - Fougeray, R. AU - Schutz, F. A. B. AU - Salhi, Y. AU - Winquist, E. PY - 2010 DA - 2010// TI - Prognostic factors in patients with advanced transitional cell carcinoma of the urothelial tract experiencing treatment failure with platinum-containing regimens JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.25.4599 DO - 10.1200/JCO.2009.25.4599 ID - Bellmunt2010 ER - TY - JOUR AU - Sonpavde, G. AU - Watson, D. AU - Tourtellott, M. AU - Cowey, C. L. AU - Hellerstedt, B. AU - Hutson, T. E. PY - 2012 DA - 2012// TI - Administration of cisplatin-based chemotherapy for advanced Urothelial carcinoma in the community JO - Clin Genitourin Cancer VL - 10 UR - https://doi.org/10.1016/j.clgc.2011.11.005 DO - 10.1016/j.clgc.2011.11.005 ID - Sonpavde2012 ER - TY - STD TI - Galsky MD. Treatment patterns and outcomes in “real world” patients (pts) with metastatic urothelial cancer (UC). J Clin Oncol. http://meetinglibrary.asco.org/content/110719-132. Accessed 11 July 2016. UR - http://meetinglibrary.asco.org/content/110719-132 ID - ref15 ER - TY - JOUR AU - Maase, H. AU - Hansen, S. W. AU - Roberts, J. T. AU - Dogliotti, L. AU - Oliver, T. AU - Moore, M. J. PY - 2000 DA - 2000// TI - Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study JO - J Clin Oncol VL - 18 ID - Maase2000 ER - TY - JOUR AU - Raggi, D. AU - Miceli, R. AU - Sonpavde, G. AU - Giannatempo, P. AU - Mariani, L. AU - Galsky, M. D. PY - 2016 DA - 2016// TI - Second-line single-agent versus doublet chemotherapy as salvage therapy for metastatic urothelial cancer: a systematic review and meta-analysis JO - Ann Oncol VL - 27 UR - https://doi.org/10.1093/annonc/mdv509 DO - 10.1093/annonc/mdv509 ID - Raggi2016 ER - TY - JOUR AU - Bellmunt, J. AU - Theodore, C. AU - Demkov, T. AU - Komyakov, B. AU - Sengelov, L. AU - Daugaard, G. PY - 2009 DA - 2009// TI - Phase III trial of vinflunine plus best supportive care compared with best supportive care alone after a platinum-containing regimen in patients with advanced transitional cell carcinoma of the Urothelial tract JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.5534 DO - 10.1200/JCO.2008.20.5534 ID - Bellmunt2009 ER - TY - JOUR AU - Bellmunt, J. AU - Fougeray, R. AU - Rosenberg, J. E. AU - Maase, H. AU - Schutz, F. A. AU - Salhi, Y. PY - 2013 DA - 2013// TI - Long-term survival results of a randomized phase III trial of vinflunine plus best supportive care versus best supportive care alone in advanced urothelial carcinoma patients after failure of platinum-based chemotherapy JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt007 DO - 10.1093/annonc/mdt007 ID - Bellmunt2013 ER - TY - JOUR AU - Retz, M. AU - Geeter, P. AU - Goebell, P. J. AU - Matz, U. AU - Schultz, W. AU - Hegele, A. PY - 2015 DA - 2015// TI - Vinflunine in routine clinical practice for the treatment of advanced or metastatic urothelial cell carcinoma - data from a prospective, multicenter experience JO - BMC Cancer VL - 15 UR - https://doi.org/10.1186/s12885-015-1434-3 DO - 10.1186/s12885-015-1434-3 ID - Retz2015 ER - TY - JOUR AU - Castellano, D. AU - Puente, J. AU - Velasco, G. AU - Chirivella, I. AU - López-Criado, P. AU - Mohedano, N. PY - 2014 DA - 2014// TI - Safety and effectiveness of vinflunine in patients with metastatic transitional cell carcinoma of the urothelial tract after failure of one platinum-based systemic therapy in clinical practice JO - BMC Cancer VL - 14 UR - https://doi.org/10.1186/1471-2407-14-779 DO - 10.1186/1471-2407-14-779 ID - Castellano2014 ER - TY - JOUR AU - Pistamaltzian, N. AU - Tzannis, K. AU - Pissanidou, V. AU - Peroukidis, S. AU - Milaki, G. AU - Karavasilis, V. PY - 2016 DA - 2016// TI - Treatment of relapsed urothelial bladder cancer with vinflunine: real-world evidence by the Hellenic Genitourinary Cancer Group JO - Anticancer Drugs VL - 27 UR - https://doi.org/10.1097/CAD.0000000000000297 DO - 10.1097/CAD.0000000000000297 ID - Pistamaltzian2016 ER - TY - STD TI - VICTOR. Vinflunine (Vin) in advanced metastatic transitional cell carcinoma of the urothelium (TCCU)—A retrospective analysis of use of Vin in multicenter, real life setting as second-line chemotherapy (ChT) through free-of charge-programme (FOCP) for patients (pts) in the UK. | 2015. Genitourinary Cancers Symposium | Abstracts | Meeting Library [Internet]. http://meetinglibrary.asco.org/content/141508-159. Accessed 11 July 2016. UR - http://meetinglibrary.asco.org/content/141508-159 ID - ref23 ER - TY - JOUR AU - Yafi, F. A. AU - North, S. AU - Kassouf, W. PY - 2011 DA - 2011// TI - First- and second-line therapy for metastatic urothelial carcinoma of the bladder JO - Curr Oncol Tor Ont VL - 18 ID - Yafi2011 ER - TY - JOUR AU - Maase, H. PY - 2003 DA - 2003// TI - Gemcitabine in transitional cell carcinoma of the urothelium JO - Expert Rev Anticancer Ther VL - 3 UR - https://doi.org/10.1586/14737140.3.1.11 DO - 10.1586/14737140.3.1.11 ID - Maase2003 ER - TY - JOUR AU - Albers, P. AU - Park, S. -. I. AU - Niegisch, G. AU - Fechner, G. AU - Steiner, U. AU - Lehmann, J. PY - 2011 DA - 2011// TI - Randomized phase III trial of 2nd line gemcitabine and paclitaxel chemotherapy in patients with advanced bladder cancer: short-term versus prolonged treatment [German Association of Urological Oncology (AUO) trial AB 20/99] JO - Ann Oncol VL - 22 UR - https://doi.org/10.1093/annonc/mdq398 DO - 10.1093/annonc/mdq398 ID - Albers2011 ER - TY - JOUR AU - Powles, T. AU - Eder, J. P. AU - Fine, G. D. AU - Braiteh, F. S. AU - Loriot, Y. AU - Cruz, C. PY - 2014 DA - 2014// TI - MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer JO - Nature VL - 515 UR - https://doi.org/10.1038/nature13904 DO - 10.1038/nature13904 ID - Powles2014 ER - TY - STD TI - Press Announcements - FDA approves new, targeted treatment for bladder cancer [Internet]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm501762.htm. Accessed 11 July 2016. UR - http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm501762.htm ID - ref28 ER - TY - JOUR AU - Rosenberg, J. E. AU - Hoffman-Censits, J. AU - Powles, T. AU - Heijden, M. S. AU - Balar, A. V. AU - Necchi, A. PY - 2016 DA - 2016// TI - Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial JO - Lancet VL - 387 UR - https://doi.org/10.1016/S0140-6736(16)00561-4 DO - 10.1016/S0140-6736(16)00561-4 ID - Rosenberg2016 ER -